INTRODUCTION {#sec1-1}
============

*Ā*malaki (*Emblica officinalis Gaertn*.) belongs to family Euphorbiaceae ascending to 1300 m on hills, abundantly available throughout India.\[[@ref1]\] The proven pharmacological properties of Amalaki are imunomodulatory activity,\[[@ref2]\] antipyretic and analgesic activity,\[[@ref3]\] hepatoprotective activity,\[[@ref4]\] cytoprotective activity,\[[@ref5]\] antitussive activity,\[[@ref6]\] gastoprotective activity,\[[@ref7]\] ophthalmic disorder,\[[@ref8]\] antibacterial activity,\[[@ref9]\] radioprotective activity,\[[@ref10]\] chemopreventive activity,\[[@ref11]\] antitumor activity,\[[@ref12]\] antiulcer activity,\[[@ref13]\] hypocholesterolemic activity,\[[@ref14]\] hypolipidemic activity,\[[@ref15]\] antimutagenic activity,\[[@ref16]\] antioxidant activity,\[[@ref17]\] anticancer activity,\[[@ref18]\] antiproliferative activity.\[[@ref19]\] There are many formulations explained in classics having *Emblica officinalis Gaertn*. as main ingredient. Although they are potent enough in treatment, they are not stable for longer duration due to their plant origin and as they are organic in nature they easily deteriorates with microbial contamination. Among those Dugdhamalakyadi Yoga\[[@ref20]\] is one important plant based preparation in which Amalaki (*Emblica officinalis Gaertn*.) powder \[[Figure 1](#F1){ref-type="fig"}\] is administered along with milk in case of swarabhanga (hoarseness of voice). To improve its shelf life, palatability and for the proper fixation of therapeutic dose, it is current essential requirement to develop Dugdhamalakyadi Yoga into chewable tablet \[[Figure 2](#F2){ref-type="fig"}\] form along with its quality analysis as per standards.

![Powder of *Emblica officinalis Gaertn*](ASL-32-34-g001){#F1}

![Chewable tablet](ASL-32-34-g002){#F2}

MATERIALS AND METHODS {#sec1-2}
=====================

*Emblica officinalis Gaertn*. was collected from the Western Ghats of Belgaum region in winter season as per mentioned in Ayurvedic classics and authenticated by AYUSH approved drug testing laboratory, KLEU\'s BMK Ayurveda Mahavidyalaya, Belgaum. Amulya milk powder was purchased from Gujarat co-operative milk marketing federation limited. The Poly vinyl pyrrolidone (PVP), Ethyl alcohol, Talc, cross caramellose sodiums were purchased from S.D.Fine Chem, Ltd. Mumbai. Methyl paraben, propyl paraben and Sucrose purchased from the local market.

The study has been conducted in KLEU\'s Ayurveda Pharmacy, Belgaum.

Methods {#sec2-1}
-------

### Preparation of Āmalaki (Emblica officinalis Gaertn.) powder {#sec3-1}

Completely dried fruit pulp of *Emblica officinalis Gaertn*. was powdered in pulveriser and passed through 100 \# sieve, powder was collected in a clean air tight jar.

### Preparation of chewable tablets (Wet granulation method) {#sec3-2}

The prepared powder is subjected for preparation of chewable tablet by wet granulation method by using non aqueous solution. Known quantity of powder is weighed according to the number of tablets to be compressed. Powder and other excipients are taken in a mortar and converted into a dough mass by adding required quantity of 10% PVP in ethanol as a granulating agent. The dough mass is passed through sieve number 10, the pallets obtained are dried in a tray drier at 60°c for 15 min. The dry granules are passed through sieve number 44, super imposed on sieve number 22 on a clean filter paper. The granules retained on sieve number 44 are collected and to this 10% of fines, the remaining quantity of sweetening agent, preservatives and suitable quantity of lubricant was added, mixed thoroughly and compressed into tablets.\[[@ref21][@ref22]\] The quantity of ingredients is as shown in the table \[[Table 1](#T1){ref-type="table"}\].

###### 

The proportion of ingredients and additives of each tablet

![](ASL-32-34-g003)

RESULTS {#sec1-3}
=======

Physico-chemical and Phyto-chemical analytical results of powder of Emblica officinalis Gaertn were compared with the standards of IP, it showed with in normal limits \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\]. The analysis of chewable tablet were showed the satisfactory results \[[Table 4](#T4){ref-type="table"}\]. And organoleptic characters of both powder and tablet also done \[[Table 5](#T5){ref-type="table"}\].

###### 

Results of physico-chemical analysis of *Āmalaki* (*Emblica officinalis Gaertn*.) powder

![](ASL-32-34-g004)

###### 

Phyto-chemical analysis of organic and Inorganic constituents of *Āmalaki* (*Emblica officinalis Gaertn*.)

![](ASL-32-34-g005)

###### 

Analysis of chewable tablet

![](ASL-32-34-g006)

###### 

Organoleptic characteristics of *Āmalaki* (*Emblica officinalis Gaertn*.) powder and chewable tablet

![](ASL-32-34-g007)

DISCUSSION AND CONCLUSION {#sec1-4}
=========================

In *Dugdhāmalakyādi* Yoga, powder of *Emblica officinalis Gaertn*. is administered along with milk in case of *svarabhaṅga* (hoarseness of voice). Here is an attempt made to develop this formulation into chewable tablets by wet granulation method by adding milk powder instead of milk, by this the property of the milk also mixed with the tablets \[[Table 6](#T6){ref-type="table"}\] and other additives also added to improve the stability of this tablet.

###### 

The nutritional information of milk powder

![](ASL-32-34-g008)

The preliminary phytochemical analysis of *Emblica officinalis Gaertn*. has shown presence of reducing sugar, monosaccharide\'s, proteins, tannins, sodium, potassium and Iron.

The organoleptic characters and analysis of (*Emblica officinalis Gaertn*.) chewable tablets are sweet in taste because of adding sweetening agent to increase palatability, light brown in colour.

Hardness is 1.8, so it can be chewed without any difficulty, Friability is 0.5% helps to carry easily with less percentage of breakage. Disintegration time 15-20 min can dissolve easily in mouth. Weight variation is ± 3% by this proper fixation of therapeutic dose can be achieved. The TLC of powder of *Emblica officinalis Gaertn*. was developed in ethyl acetate and toluene in ratio 1:9 v/v solvent system. Under 254 nm it showed 3 spots with Rf value 0.14, 0.4, and 0.73 \[[Figure 3](#F3){ref-type="fig"}\] and the chewable tablets showed 2 spots with Rf value 0.31 and 0.89 \[[Figure 4](#F4){ref-type="fig"}\].

![TLC of alcoholic extract of *Emblica officinalis Gaertn*](ASL-32-34-g009){#F3}

![TLC of chewable tablet](ASL-32-34-g010){#F4}

The TLC of powder and chewable tablets shows the following results

Name of the product: Āmalaki powder (*Emblica officinalis Gaertn*.)Solvent system used: Ethyl acetate and toluene (1:9).Adsorbent: Silica Plate.Spray reagent: Iron chamber.No of spots: Powder of *Emblica officinalis Gaertn* -- 3 spots.Chewable tabletof *Emblica officinalis Gaertn* -- 2 spots.Rf values: Powder of *Emblica officinalis Gaertn* --0.14, 0.4, and 0.73. Chewable tablet of *Emblica officinalis Gaertn* --0.31 and 0.89.

The TLC studies give an idea of presence of constituents of initial drugs in final product. TLC of churna was compared with CT.

Spots obtained in powder were near with those in the chewable tablets. Spots with similar or close Rf values in the finished product may be due to identical compounds and these spots confirm the presence of genuine ingredients in the finished product. The spots missing in chewable tablets may be due to presence of additives and process effect.

The adaptation of modern techniques or methods to convert the Ayurvedic formulations without altering its therapeutic property is necessary to made them suitable for the present trends of newer drug delivery dosage forms.
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